270 related articles for article (PubMed ID: 23918169)
21. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I
Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
[TBL] [Abstract][Full Text] [Related]
23. Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis.
Gossen N; Jacob L; Kostev K
Rheumatol Int; 2016 Aug; 36(8):1113-8. PubMed ID: 26936261
[TBL] [Abstract][Full Text] [Related]
24. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
Rajakulendran S; Gadsby K; Deighton C
Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
[TBL] [Abstract][Full Text] [Related]
25. Claims for disease-modifying therapy by Alberta non-insured health benefits clients.
Barnabe C; Healy B; Portolesi A; Kaplan GG; Hemmelgarn B; Weaselhead C
BMC Health Serv Res; 2016 Aug; 16(1):430. PubMed ID: 27557840
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and incidence of rheumatoid arthritis in South Korea.
Sung YK; Cho SK; Choi CB; Bae SC
Rheumatol Int; 2013 Jun; 33(6):1525-32. PubMed ID: 23255140
[TBL] [Abstract][Full Text] [Related]
27. Validity of ankylosing spondylitis diagnoses in The Health Improvement Network.
Dubreuil M; Peloquin C; Zhang Y; Choi HK; Inman RD; Neogi T
Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):399-404. PubMed ID: 26762622
[TBL] [Abstract][Full Text] [Related]
28. Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study.
Angelici L; Addis A; Agabiti N; Kirchmayer U; Davoli M; Belleudi V
Medicine (Baltimore); 2021 May; 100(19):e25943. PubMed ID: 34106665
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients.
Park EH; Shin A; Ha YJ; Lee YJ; Lee EB; Song YW; Kang EH
Joint Bone Spine; 2021 Jan; 88(1):105057. PubMed ID: 32711117
[TBL] [Abstract][Full Text] [Related]
30. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
[TBL] [Abstract][Full Text] [Related]
31. [Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data].
Neubauer S; Zeidler H; Linder R; Zeidler J
Dtsch Med Wochenschr; 2019 Jun; 144(12):e70-e79. PubMed ID: 30654405
[TBL] [Abstract][Full Text] [Related]
32. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance.
Widdifield J; Bombardier C; Bernatsky S; Paterson JM; Green D; Young J; Ivers N; Butt DA; Jaakkimainen RL; Thorne JC; Tu K
BMC Musculoskelet Disord; 2014 Jun; 15():216. PubMed ID: 24956925
[TBL] [Abstract][Full Text] [Related]
33. Disease modification in rheumatoid arthritis with leflunomide.
Emery P
Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid Arthritis and Risk of Parkinson Disease in Korea.
Kang J; Eun Y; Jang W; Cho MH; Han K; Jung J; Kim Y; Kim GT; Shin DW; Kim H
JAMA Neurol; 2023 Jun; 80(6):634-641. PubMed ID: 37126341
[TBL] [Abstract][Full Text] [Related]
36. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
Edwards CJ; Arden NK; Fisher D; Saperia JC; Reading I; Van Staa TP; Cooper C
Rheumatology (Oxford); 2005 Nov; 44(11):1394-8. PubMed ID: 16030083
[TBL] [Abstract][Full Text] [Related]
37. A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. Results from the RECord linkage On Rheumatic Diseases study of the Italian Society for Rheumatology.
Carrara G; Scirè CA; Zambon A; Cimmino MA; Cerra C; Caprioli M; Cagnotto G; Nicotra F; Arfè A; Migliazza S; Corrao G; Minisola G; Montecucco C
BMJ Open; 2015 Jan; 5(1):e006029. PubMed ID: 25631308
[TBL] [Abstract][Full Text] [Related]
38. Validation of claims-based algorithms for rheumatoid arthritis in Japan: Results from the VALIDATE-J study.
Sugiyama N; Kinjo M; Jinno S; de Luise C; Morishima T; Higuchi T; Katayama K; Chen H; Nonnenmacher E; Hase R; Suzuki D; Tanaka Y; Setoguchi S
Int J Rheum Dis; 2024 Jan; 27(1):e15001. PubMed ID: 38160436
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
[TBL] [Abstract][Full Text] [Related]
40. The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
Almutairi K; Inderjeeth C; Preen DB; Keen H; Rogers K; Nossent J
Rheumatol Int; 2021 Apr; 41(4):741-750. PubMed ID: 33620516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
